ISSN

0974-4150 (Online)
0974-4169 (Print)


Author(s): C.Buvana, A. Sumathy, M. Sukumar

Email(s): Boviblue@gmail.com

DOI: Not Available

Address: C.Buvana1, A. Sumathy1, M. Sukumar2
1Dept. of Pharmaceutical Chemistry, Grace College of Pharmacy, Palakkad-678004
2Dept. of Pharmaceutical Analysis, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore.
*Corresponding Author

Published In:   Volume - 6,      Issue - 11,     Year - 2013


ABSTRACT:
Binding interactions of drugs using docking studies is an important component of computer aided drug design. Structure-based lead optimization approaches are a major role in the drug-discovery process. XO(xanthine oxidase) is the key enzyme that catalyzes the oxidation of hypoxanthine to xanthine and then to uric acid. Hyperuricemia is an underlying cause of gout and cardiovascular diseases. Allopurinol, a widely used XO inhibitor and commonly used drug to treat gout. However, a significant portion of the population suffers from adverse effects of allopurinol like gastrointestinal upset and skin rashes. Therefore use of allopurinol-like drugs with minimum side effects is the ideal drug of choice against gout. A series of indole linked with thiazolidinone were computationally designed and energy minimized. The molecular properties were calculated from suitable computational tools. These ligands were investigated for drug like properties by calculating Lipinski’s rule of five using molinspiration. All of the derivatives showed a zero violations of the rule of 5 which indicates good bioavailability. The positive bioactivity score of the derivative were also in agreement with their probability of drug likeness. These compounds were docked into the active site of XO (PDB code-1HZP) using Argus lab docking software which showed good binding energy for the enzyme, when compared with the binding energies of standard drug allopurinol (-6.91kcal/mol.) Among all the designed ligands, the ligand TZ2 and TZ4 showed more binding energy values (-10.074 and = -9.158Kcal/mol). These results highlight the identification of a new class of XO inhibitors that have potential to be more efficacious, than allopurinol, to treat gout and against cardiovascular diseases. In future we planned to synthesise these ligand and to screen for their xanthine oxidase inhibitory activity.


Cite this article:
C.Buvana, A. Sumathy, M. Sukumar. In silico Identification of Potential Xanthine Oxidase Inhibitors for the Treatment of Gout and Cardiovascular Disease. Asian J. Research Chem. 6(11): November 2013; Page 1049-1053.


Recomonded Articles:

Author(s): Prathima Patil, S.P. Sethy, T. Sameena, K. Shailaja

DOI:         Access: Open Access Read More

Author(s): Pankaj Baboo, Girendra Gautam, S.K. Gupta

DOI: 10.5958/0974-4150.2017.00039.6         Access: Open Access Read More

Author(s): Sindhu. T. J, Akhilesh K. J, Anju. Jose, Binsiya K. P, Blessy Thomas, Elizabeth Wilson

DOI: 10.5958/0974-4150.2020.00026.7         Access: Closed Access Read More

Author(s): Sabale Prafulla, Potey Lata, Rahangdale Priya, Sabale Vidya

DOI: 10.5958/0974-4150.2019.00011.7         Access: Open Access Read More

Author(s): A.K. Meena, M.M. Rao, Kiran Sharma, Ajay Yadav, Uttam Singh, Amit

DOI:         Access: Open Access Read More

Author(s): Salifou Karimoune Fadjimata, Adamou Rabani, Adamou Hassane Hassane, Ayouba Mahamane Abdoulkadri

DOI: 10.5958/0974-4150.2020.00027.9         Access: Closed Access Read More

Author(s): Sandip N. Badeliya, Dhrubo Jyoti Sen

DOI:         Access: Open Access Read More

Author(s): Tanveer Hasan, Raza Murad Ghalib, Sayed Hasan Mehdi, P. K. Singh, S. S. R. Baqri

DOI: 10.5958/0974-4150.2017.00132.8         Access: Open Access Read More

Author(s): Firke SD, Firake BM, Chaudhari RY, Patil VR

DOI:         Access: Open Access Read More

Author(s): M. Govindammal, M. Prasath, B. Sathya, M. Selvapandiyan

DOI: 10.5958/0974-4150.2017.00079.7         Access: Open Access Read More

Author(s): Ashok Kumar, Meera, Sunita Lega, Satyender K. Yadav

DOI: 10.5958/0974-4150.2017.00120.1         Access: Open Access Read More

Author(s): Subhasish Chaudhur, Biswajit Chandra Das

DOI:         Access: Open Access Read More

Author(s): Bhavna Patel, Zarna Dedania, Ronak Dedania, Chetan Ramolia, G Vidya Sagar, Mehta RS

DOI:         Access: Open Access Read More

Author(s): Tiwari Preeti, Patel RK

DOI:         Access: Open Access Read More

Author(s): N V L Suvarchala Reddy V, Sneha J Anarthe, Ganga Raju M, Akhila M, Pooja Raj G.B.

DOI: 10.5958/0974-4150.2019.00020.8         Access: Open Access Read More

Asian Journal of Research in Chemistry (AJRC) is an international, peer-reviewed journal devoted to pure and applied chemistry..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0974-4150 

Popular Articles


Recent Articles




Tags